Johnson & Johnson Advances Coronavirus Vaccine Candidate; EUA Likely In Early 2021

Johnson & Johnson has joined the big league of frontrunners in the coronavirus vaccine race following its announcement concerning the initiation of the Phase 3 study.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.